From Presence to Impact: SCDM India 2025 by Parangusan Kalisrinivasa, Data Management Manager Read the full story
Stronger Together

Excelya Successfully Renews ISO 27001 Certification

Zero Findings Success

Excelya is delighted to share a significant achievement that reinforces our ongoing dedication to security, quality and trust. We have successfully received our ISO 27001 recertification, valid until October 2028, following a detailed external audit carried out by Swiss Approval International on October 16th, 2025.

This recertification was granted with zero findings, a remarkable outcome that highlights the strength of our Information Security Management System and the daily commitment of our teams across the organization. Protecting the data of our clients and partners is a responsibility we embrace with rigor and pride, and this result reflects the maturity and reliability of our approach.

The project was driven by our Global Quality Assurance Department, working closely with our IT Department and all contributors involved throughout the process. Their work demonstrates how our values of Audacity, Care and Energy influence everything we do and how they guide us toward the highest standards in our industry.

This new milestone not only reinforces Excelya’s position as a trusted partner in clinical research but also underlines our continued focus on operational excellence, regulatory compliance and continuous improvement. As we move forward, we remain fully committed to safeguarding information, strengthening our systems and delivering the dependable support our clients expect.

To learn more about our services or to discuss how we can support your projects, please submit your request.

Nous sommes Excelya

Excelya s’engage à aider nos clients à offrir des thérapies qui changent la vie de manière collaborative, afin que nous puissions transformer demain ensemble.

Notre réseau mondial d’experts dans 28 pays comprend vos besoins critiques pour fournir des solutions d’essais sur mesure et robustes dans un large éventail de domaines thérapeutiques avec soin.

Nous soutenons les organisations biotechnologiques, pharmaceutiques et de dispositifs médicaux pour réaliser des avancées en santé. Notre modèle économique unique nous permet de fournir des solutions de qualité, flexibles et expertes, complètes et complètes pour les CRO, FSP et ressources.